Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities. (2022)
Attributed to:
Modelling neuronal dysfunction in early onset epilepsies; a patient-centric approach
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fnmol.2022.941528
PubMed Identifier: 35836547
Publication URI: http://europepmc.org/abstract/MED/35836547
Type: Journal Article/Review
Volume: 15
Parent Publication: Frontiers in molecular neuroscience
ISSN: 1662-5099